Sarah Finley
Project Management

Sarah started her career in medicinal chemistry and has held research positions at Pfizer, Tularik and Theravance BioPharma.

At Theravance, Sarah’s team was responsible for the research leading to the discovery and development of the drug Yupelri (revefenacin). More recently she has been involved in clinical trial organization and execution on the patient side at Nucleus Network, and on the company side for Genentech.

Sarah has a BS in chemistry from Bates College.